Articles From: Glori Energy Provides Operations Update to CASI Pharmaceuticals Highlights 2014 Accomplishments And 2015 Milestones


-- Progress on AERO deployment in Coke Field continues --
Sign-up for Glori Energy Provides Operations Update investment picks
TrueBlue, Inc. (NYSE:TBI) will release 2014 fourth quarter and full-year results Thursday, Feb.
Sign-up for TrueBlue to Announce 2014 Fourth Quarter and Full-Year Results investment picks
World Point Terminals, LP (the “Partnership”), a Delaware limited partnership (NYSE: WPT), announced today that the board of directors of its general partner declared a cash distribution of $0.30 per unit ($1.20 per unit on an annualized basis) for the period from October 1, 2014 through December 31, 2014.
Sign-up for World Point Terminals, LP Announces Quarterly Distribution investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030613-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/15/11G030613/Infonetics-IHS-transitional-logo-horizontal-713773396356.jpg http://www.marketwire.com/library/MwGo/2015/1/15/11G030613/Images/2014-Infonetics-Mobile-M2M-Modules-by-Technology-M-1308346435585.jpg M2M and IoT are transforming industries and creating tremendous opportunities for mobile M2M module vendors around the world CAMPBELL, CA--(Marketwired - January 15, 2015) - Technology market research firm Infonetics Research , now part of IHS Inc. (NYSE: IHS), today released excerpts from its latest Mobile M2M Modules report, which provides market share, market size, forecasts, analysis and trends for mobile machine-to-machine (M2M) modules by technology, vertical and region.
Sign-up for Infonetics: Mobile M2M Module Market to Grow Nearly Three-fold to $4.5 Billion by 2018 investment picks
Citizens Financial Group (NYSE: CFG) announced today that Chairman and Chief Executive Officer Bruce Van Saun will present at the 16 th Annual Credit Suisse Financial Services Forum on Tuesday, February 10, 2015 at 2:30 p.m. ET.
Sign-up for Citizens Financial Group to Present at the 16th Annual Credit Suisse Financial Services Forum investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987892001&sourceType=1 http://media3.marketwire.com/logos/20140428-GASFRAC%20.jpg CALGARY, ALBERTA --
Sign-up for GASFRAC Files for CCAA Protection investment picks
Continued Execution of Core Strategies Drives Strong Quarterly and Yearly Performance ATLANTA , Jan.
Sign-up for SunTrust Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Peerless Systems Corp.
Sign-up for SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Peerless Systems Corp. investment picks
- In Phase 3 clinical trials, VIEKIRAX + EXVIERA cured 95-100 percent of genotype 1 chronic hepatitis C patients, with less than 2 percent of patients experiencing virologic failure[1],[2] - Tolerability profile shows more than 98 percent of patients completed a full course of therapy[3] - All-oral, interferon-free regimen also approved for HCV/HIV-1 co-infection, patients on opioid substitution therapy and patients who have undergone a liver transplant[1],[2] - VIEKIRAX + EXVIERA are the first products to be approved as a combination treatment of three direct-acting antivirals with distinct mechanisms of action targeting hepatitis C at multiple steps in the viral lifecycle[1],[2] NORTH CHICAGO, Ill.
Sign-up for European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C investment picks
LAKE FOREST, Ill., Jan.
Sign-up for Akorn Confirms Generic Durezol(R) Patent Challenge investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987865001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg http://www.ccnmatthews.com/logos2/virginia.jpg MONTREAL, QUEBEC and QUEBEC CITY, QUEBEC --
Sign-up for Osisko and Virginia: Business Combination Receives Court Approval investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987817001&sourceType=1 http://media3.marketwire.com/logos/20141009-enbridgeenf.jpg CALGARY, ALBERTA --
Sign-up for Enbridge Income Fund Holdings Inc. Announces Monthly Dividend investment picks
NEW YORK, Jan.
Sign-up for FXCM Comments on Swiss Franc Movement investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030621-001&sourceType=1 NEW YORK, NY--(Marketwired - January 15, 2015) - JetBlue Airways Corporation (NASDAQ: JBLU) announced today that it will hold its quarterly conference call to discuss fourth quarter and full year 2014 financial results on January 29, 2015 at 10:00 a.m. ET.
Sign-up for JetBlue Announces Webcast of Fourth Quarter 2014 Earnings Conference Call investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987873001&sourceType=1 http://media3.marketwire.com/logos/20140604-cogeco_200.jpg MONTREAL, QUEBEC --
Sign-up for Cogeco Inc. Announces Voting Results on the Election of Directors Held During its Annual Shareholders' Meeting investment picks
Intermap Completes US$500,000 Debt Financing Canada NewsWire DENVER , Jan.
Sign-up for Intermap Completes US$500,000 Debt Financing investment picks
The Wet Seal, Inc. (Nasdaq: WTSL), a specialty retailer to young women, today announced that it has filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on January 15, 2015.
Sign-up for Wet Seal Files for Chapter 11 Bankruptcy Protection investment picks
Enanta Announces European Commission Grants Marketing Authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Genotypes 1 and 4 Chronic Hepatitis C Virus Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that the European Commission has granted marketing authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) 1,2 with or without ribavirin (RBV) for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
Sign-up for Enanta Announces European Commission Grants Marketing Authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets)... investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987858001&sourceType=1 http://media3.marketwire.com/logos/20120224-hudbaylogoa.jpg TORONTO, ONTARIO --
Sign-up for Hudbay Announces 2015 Production Guidance and Capital and Exploration Expenditure Forecasts investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987888001&sourceType=1 http://www.ccnmatthews.com/logos/20100302-trilogy.jpg CALGARY, ALBERTA --
Sign-up for Trilogy Announces 2014 Results and Updates 2015 Guidance investment picks
PENNSAUKEN, N.J., Jan.
Sign-up for J & J Snack Foods Schedules First Quarter Conference Call investment picks
Transocean Ltd.
Sign-up for Transocean Files 8K - Regulation FD investment picks
Full-Year 2014 Net Income of $593 Million, or $3.16 Per Share Broad-Based Loan and Deposit Growth Compared to Full-Year 2013 Average Loans Up $2.2 Billion, or 5 Percent Average Deposit Growth of $3.1 Billion, or 6 Percent Drive for Efficiency Demonstrated in Well-Controlled Expenses Credit Quality Remains Strong 5.2 Million Shares Repurchased in 2014 Under the Share Repurchase Program; $392 Million or 66 Percent of 2014 Net Income Returned to Shareholders DALLAS , Jan.
Sign-up for Comerica Reports Fourth Quarter 2014 Net Income Of $149 Million, Or 80 Cents Per Share investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Glori Energy Provides Operations Update to CASI Pharmaceuticals Highlights 2014 Accomplishments And 2015 Milestones
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent